Effect of Low Doses of Hypoxia-inducible Factor- Prolyl Hydroxylase Enzyme Inhibitor Plus Iron in the Treatment of Anemia in Dialysis-dependent Chronic Kidney Disease Patients

Conditions: Anemia in Dialysis-dependent CKD Patients Interventions: Drug: Roxadustat Sponsors: Alexandria University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials